Patent details

Basic Information

Publication number:

91339

Type:

SPC

SPC Type:

Medical

Basic Patent Number:

EP971134341

Legal Status:

Expired

Application number:

91339

First applicant's nationality:

Procedural language:

French

Paediatric Extension

SPC Extension Filing Date:

19/11/2014

SPC Extension Agent Name:

OFFICE FREYLINGER S.A. , G.D.SEARLE LLC

SPC Extension Status:

Granted

SPC Extension Grant Date:

04/02/2015

SPC Extension Rejection Date:

Marketing Authorization

Marketing Authorization Number:

EU/1/06/380/001 Prezista-darunavir

Marketing Authorization Type:

Marketing Authorization Date:

12/02/2007

Marketing Authorization Status:

Accepted

Marketing Authorization Country:

Dates

Filing date:

23/05/2007

First Marketing Authorization date:

12/02/2007

Grant date:

23/07/2007

Activation date:

24/08/2013

Publication date:

23/07/2007

Lapsed date:

Expiration date:

Renunciation date:

Revocation date:

Annulment date:

Basic SPC Expiration:

24/08/2018

SPC Extension Expiration:

24/02/2019

Rejection date:

Withdrawal date:

Owner

From:

23/05/2007

 

 

Name:

G.D.SEARLE LLC

Address:

EAST 42ND STREET 235, NEW YORK, NY 10017, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

23/05/2007

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

Decrescenzo Gary A.

Address:

United States (US)

2

Name:

Mueller Richard A.

Address:

United States (US)

3

Name:

Vazquez Michael L.

Address:

United States (US)

4

Name:

Freskos John N.

Address:

United States (US)

5

Name:

Talley John J.

Address:

United States (US)

6

Name:

Getman Daniel

Address:

United States (US)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

06/07/2017

Last Annual Fee Paid Number:

25

Last Annual Fee Paid Amount:

450 Euro

Payer:

MDC (HENKEL PATENT)

Filing date	Document type	Number of pages